Literature DB >> 30548492

Association of group-specific component exon 11 polymorphisms with bronchial asthma in children and adolescents.

Manal S Fawzy1,2, Mona G Elgazzaz3, Ahmed Ibrahim4, Mohammad H Hussein5, Moataz S Khashana6, Eman A Toraih3,7.   

Abstract

Several studies have investigated the association of Group-specific Component (GC) gene, also known as vitamin D-binding protein (VDBP), and various respiratory disorder susceptibility with conflicting results. In this sense, we aimed to investigate whether rs7041 and rs4588 variants confer susceptibility to bronchial asthma in a sample of an Egyptian population and to elucidate by in silico analysis the structural and functional impact of these variants. Group-specific Component polymorphisms rs7041 and rs4588 were genotyped in 192 Egyptian children and adolescents (96 with asthma and 96 healthy controls) by TaqMan single nucleotide polymorphism genotyping assay. The rs7041 GG genotype showed a significantly elevated frequency among patients under codominant, dominant, recessive and allelic models where the patient group had greater carriage rate of G allele [OR 2.15, CI 95% (1.32-3.50; P = 0.002)], while rs4588 CA and AA genotypes were found to be protective genotypes with controls showing a greater carriage rate of A allele [OR 0.52, CI 95% (0.30 - 0.90; P = 0.02)]. Three haplotype allele combinations were identified with frequencies of GC (44.3%), TC (31.3%) and TA (24.5%) in the total study population. GC haplotype was shown to be more frequent in controls, while TC and TA haplotypes were more predominant in the patient group. Only rs7041 variant showed a significant association with family history and pubertal status. In conclusion, both study GC variants could be implicated in childhood bronchial asthma pathogenesis; rs7041 GG genotype and G allele increased asthma risk while rs4588 AA genotype and A allele conferred protection in the study population.
© 2018 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  Egyptian; VDBP, single nucleotide polymorphism; bronchial asthma; group-specific component gene; haplotype; real-time PCR

Mesh:

Substances:

Year:  2019        PMID: 30548492     DOI: 10.1111/sji.12740

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Association of VDBP rs4701 Variant, but not VDR/RXR-α Over-Expression with Bone Mineral Density in Pediatric Well-Chelated β-Thalassemia Patients.

Authors:  Shaimaa Sahmoud; Mostafa S Ibrahim; Eman A Toraih; Noha Kamel; Manal S Fawzy; Samar Elfiky
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-07-01       Impact factor: 2.576

Review 2.  Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa.

Authors:  Anu Laulajainen-Hongisto; Annina Lyly; Paula Kauppi; Sanna Toppila-Salmi; Tanzeela Hanif; Kishor Dhaygude; Matti Kankainen; Risto Renkonen; Kati Donner; Pirkko Mattila; Tuomas Jartti; Jean Bousquet
Journal:  Clin Transl Allergy       Date:  2020-10-28       Impact factor: 5.871

Review 3.  Association of vitamin D gene polymorphisms in children with asthma - A systematic review.

Authors:  Narmada Ashok; Richard Kirubakaran; Radha Saraswathy
Journal:  Heliyon       Date:  2020-09-01

4.  Association of vitamin D genetic pathway with asthma susceptibility in the Kurdish population.

Authors:  Rasoul Nasiri-Kalmarzi; Mohammad Abdi; Javad Hosseini; Somayeh Tavana; Aram Mokarizadeh; Rezgar Rahbari
Journal:  J Clin Lab Anal       Date:  2019-09-20       Impact factor: 2.352

Review 5.  Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases.

Authors:  Dominika Rozmus; Alicja Ciesielska; Janusz Płomiński; Roman Grzybowski; Ewa Fiedorowicz; Natalia Kordulewska; Huub Savelkoul; Elżbieta Kostyra; Anna Cieślińska
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

Review 6.  rs7041 and rs4588 Polymorphisms in Vitamin D Binding Protein Gene (VDBP) and the Risk of Diseases.

Authors:  Dominika Rozmus; Janusz Płomiński; Klaudia Augustyn; Anna Cieślińska
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.